Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?

por Soudet, S., Jedraszak, G., Evrard, O., Marolleau, J.P., Garcon, L., Pietri, M.A. Sevestre
Publicado 2021

Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review

por Etienne, A., Gruson, B., Chatelain, D., Garidi, R., Royer, B., Sevestre, H., Marolleau, J. P., Damaj, G.
Publicado 2009

P1404: HDAC6 REGULATES HUMAN ERYTHROID DIFFERENTIATION THROUGH MODULATION OF JAK2 SIGNALING

por Vong, P., Messaoudi, K., Jankovsky, N., Caulier, A., Demont, Y., Boyer, T., Marolleau, J.-P., Rochette, J., Houled Haddou, H., Garcon, L.
Publicado 2022

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

por Desgrandchamps, F, Teren, M, Cortivo, L Dal, Marolleau, J-P, Bertheau, P, Villette, J-M, Cortesse, A, Teillac, P, Duc, A Le, Hamdy, F C
Publicado 1999

Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma

por Schmidt-Tanguy, A., Houot, R., Lissandre, S., Abgrall, J. F., Casassus, P., Rodon, P., Desablens, B., Marolleau, J. P., Garidi, R., Lamy, T., Moles-Moreau, M.-P., Damaj, G.
Publicado 2014

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

por Cottu, P H, Extra, J M, Espie, M, Marolleau, J P, Roquancourt, A de, Makke, J, Miclea, J M, Laurence, V, Mayeur, D, Lerebours, F, Cuvier, C, Marty, M
Publicado 2001

P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF...

por Zinzani, P. L., Ansell, S. M., Bosch, F., Friedberg, J. W., Marolleau, J. P., Arcaini, L., Garcia-Sanz, R., Gopal, A. K., Grande, C., Merryman, R., Pinto, A., Smith, S. D., Villasboas, J. C., Wallace, D., Fagerberg, J., Magalhaes, J. G., Armand, P.
Publicado 2022

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

por Chabannon, C., Cornetta, K., Lotz, J. P., Rosenfeld, C., Shlomchik, M., Yanovitch, S., Marolleau, J. P., Sledge, G., Novakovitch, G., Srour, E. F., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, D., Maraninchi, D., Mills, B., Kunkel, L., Oldham, F., Blaise, D., Viens, P.
Publicado 1998

P872: DEL(1P32) REMAINS A POWERFUL PROGNOSTIC FACTOR IN A LARGE COHORT OF NDMM PATIENTS: AN UPDATE

por Schavgoulidze, A., Perrot, A., Cazaubiel, T., Leleu, X., Manier, S., Buisson, L., Maheo, S., Do Souto Ferreira, L., Lannes, R., Pavageau, L., Hulin, C., Marolleau, J.-P., Voillat, L., Belhadj, K., Divoux, M., Slama, B., Brechignac, S., Macro, M., Stoppa, A.-M., Sanhes, L., Orsini-Piocelle, F., Fontan, J., Chretien, M.-L., Demarquette, H., Mohty, M., Avet-Loiseau, H., Corre, J.
Publicado 2022

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

por Hunault-Berger, M, Maillard, N, Himberlin, C, Recher, C, Schmidt-Tanguy, A, Choufi, B, Bonmati, C, Carré, M, Couturier, M-A, Daguindau, E, Marolleau, J-P, Orsini-Piocelle, F, Delaunay, J, Tavernier, E, Lissandre, S, Ojeda-Uribe, M, Sanhes, L, Sutton, L, Banos, A, Fornecker, L M, Bernard, M, Bouscary, D, Saad, A, Puyade, M, Rouillé, V, Luquet, I, Béné, M C, Hamel, J-F, Dreyfus, F, Ifrah, N, Pigneux, A
Publicado 2017